Press Release
medac GmbH: New Management structure
News
A reliable diagnosis with the new cPass test by medac GmbH
Is it possible that I’m already immune to COVID-19?
In the time of lockdowns and vaccination chaos, a new diagnostic procedure finally provides...
medac statement on Coronavirus (SARS-CoV-2)
At this moment in time, and after consultation of the competent authorities, we do not foresee any interruptions in production and therefore no supply...
Trecondi® - the new original from medac
After 20 years of intensive research and development activity in the field of haematology and oncology, medac received EU-wide marketing authorisation...
NEW in the Haematology Portfolio: Carmustin Obvius
With the launch of Carmustin Obvius in Germany, the Haematology Portfolio has been augmented by an additional substance.
The active substance...
Delivery failure urokinase
Urokinase medac is not available at the moment. At present, work is underway on a new production of the drug in order to provide patients with...
medac at the EBMT 2019
Innovative conditioning therapy for MDS and AML